Battery of tests for studying the adaptogenic effects of biologically active substances in preclinical trials

Abstract

Based on the materials of the article, the authors offer researchers of the problems of adaptation and the study of specific adaptogenic activity standardized approaches to biomedical (preclinical) research of new biologically active substances, ensuring their comparability. The analysis of modern views on adaptation processes, as an increase in nonspecific resistance to adaptive effects, and the properties of known adaptogens is carried out. It has been shown that adaptogenic action can be realized through the involvement of several regulatory pathways, such as changes in the activity of neurons and endocrine response in response to adverse effects, interaction with cell receptors and modulation of their sensitivity to endogenous regulators, changes in the composition of cell membranes, structure of the cytoskeleton, activities of enzyme complexes, epigenomic regulation, antioxidant and antiradical activity. A grouping of methods for the experimental study of adaptogens is proposed on the basis of their compliance with the definition of this pharmacological class and the requirements of evidence-based medicine. The groups of methods aimed at increasing the rate and stability of the formation of a state of increased resistance to adverse influences, reparative-restorative processes, nonspecific resistance, psychoactivating and neuroplastic effects, antimutagenic and anticarcinogenic effects were identified. Specific schemes of adaptive influences and criteria for assessing adaptogenic activity are proposed on the basis of comparing the results obtained with the effects of reference adaptogens. The technology of the integrated assessment of the results of the methods, which are different in their informational significance, has been substantiated.